ADOLESCENKINJA SA COVID19 PNEUMONIJOM I IMUNODEFICIJENCIJOM

Autori

  • Vesna Veković
  • Zorica Živković Medicinski centar „Dr Dragiša Mišović“, Dečija bolnica za plućne bolesti i tuberkulozu, Beograd, Srbija, Farmaceutski fakultet Novi Sad, Privredna akademija u Novom Sadu, Novi Sad, Srbija
  • Olivera Ostojić Medicinski centar „Dr Dragiša Mišović“, Dečija bolnica za plućne bolesti i tuberkulozu, Beograd, Srbija
  • Olivera Stojanović Medicinski centar „Dr Dragiša Mišović“, Dečija bolnica za plućne bolesti i tuberkulozu, Beograd, Srbija
  • Ivana Ćurić Medicinski centar „Dr Dragiša Mišović“, Dečija bolnica za plućne bolesti i tuberkulozu, Beograd, Srbija
  • Milica Matić Medicinski centar „Dr Dragiša Mišović“, Dečija bolnica za plućne bolesti i tuberkulozu, Beograd, Srbija

Apstrakt

Covid 19 infekcija kod dece u većini slučajeva je asimptomatska ili deca razviju blažu kliničku sliku. Većina dokaza sugeriše da deca imaju nižu incidencu razvoja teškog akutnog respiratornog sindroma usled infekcija virusom korona 2 (SARS-CoV-2). Ovo je prikaz slučaja težeg oblika COVID-19 infekcije kod ranije zdrave, 17-godišnje devojke, sa upalom pluća, temperaturom preko 38c i hipoksijom. Gojaznost je bila faktor rizika za teži klinički tok bolesti. S obzirom na produženu povišenu temperaturtu, hiposaturaciju i posledično dugotrajnu potrebu sa kiseoničnom potporom, izvršeno je dopunsko ispitivanje, te dijagnostikovana hipoagamaglobulinemija. Ova pacijentkinja je imala jedan od najviših CT skorova, 19 od 25. Pored suplementacijae kiseonikom, sistemske primene kortikosteroida, kod adolescentkinje je primenjena i supstituciona terapija imunoglobulinima. Pacijentkinja se oporavila i otpuštena je 23. dana iz bolnice radi nastavka lečenja novootkrivene hipogamaglobulinemije u regionalnom zdravstvenom centru.

Reference

Strauss SR, Knight J. Influence of the Home Environment on the Development of Obesity in Children Pediatrics (1999) 103 (6): e85. Pediatrics (1999) 103 (6): e85. https://doi.org/10.1542/peds.103.6.e85.

Lorenzo C, Williams K, Hunt JK, Haffner MS. The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care 1 January 2007; 30 (1): 8–13. https://doi.org/10.2337/dc06-1414.

DeBoer. M.D. Assessing and Managing the Metabolic Syndrome in Children and Adolescents. Nutrients 2019, 11, 1788. https://doi.org/10.3390/nu11081788.

Salmenniemi U, Ruotsalainen E, Pihlajamäki J, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation. 2004;110(25):3842-3848. doi:10.1161/01.CIR.0000150391.38660.9B.

Taher R, Sara JD, Heidari B, Toya T, Lerman LO, Lerman A. Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men. Diabetes Metab Syndr Obes. 2019;12:1035-1045. doi:10.2147/DMSO. S204666.

Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019.J Clin Invest. 2020;130(5):2620-2629. doi:10.1172/JCI137244

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5.

Bonaventura A, Vecchié A, Dagna L, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319-329. doi:10.1038/s41577-021-00536-9.

Denson JL, Gillet AS, Zu Y, et al. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. JAMA Netw Open. 2021;4(12):e2140568. doi:10.1001/jamanetworkopen.2021.40568.

Nogueira-de-Almeida CA, Ciampo LA, Ferraz IS, Ciampo IR, Contini AA, Ued FV. COVID-19 and obesity in childhood and adolescence: a clinical review. J Pediatr (Rio J). 2020;96:546-58.. Jornal de Pediatria [online]. 2020, v. 96. Epub 11 Nov 2020. ISSN 1678-4782. https://doi.org/10.1016/j.jped.2020.07.001.

Živković Z, et al. What is about Covid Pneumonia in Children? Covid pneumonija kod dece? Journal of the Association of Preventive Paediatrics of Serbia. Volume 7, May 2021 Number 1-2. ISSN 2466-3247. COBISS.SR-ID 219373324.

Harwood R, Yan H, Talawila Da Camara N, Smith C, Ward J, Tudur-Smith C, Linney M, Clark M, Whittaker E, Saatci D, Davis PJ, Luyt K, Draper ES, Kenny SE, Fraser LK, Viner RM. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis. EClinicalMedicine. 2022 Feb;44:101287. doi:10.1016/j.eclinm.2022.101287. Epub 2022 Feb 11. PMID: 35169689; PMCID: PMC8832134.

Say D., Crawford N., McNab S., Wurzel D., Steer A., Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22–ee3. - PMC - PubMed.

Pimenta, F.M.C.A. et al. Hypogammaglobulinemia: a diagnosis that must not be overlooked. Brazilian Journal of Medical and Biological Research.2019;(52)10. https://doi.org/10.1590/1414-431X20198926.

Yesillik S, Musabak U, Sener O, Baysan A, Ucar E, Demirel F, et al. The diagnosis of common variable immunodeficiency in adults should not be missed: a delayed diagnosis can be devastating. Allergol Immunopathol 2014; 42: 620– 622, doi: 10.1016/j.aller.2013.05.007.

##submission.downloads##

Objavljeno

03/29/2022

Broj časopisa

Prev Ped 2022: 8(1-2)

Sekcija

Prikazi slučaja